EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 16 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,250 | -66.9% | 30,854 | -58.3% | 0.00% | – |
| Q4 2022 | $3,778 | +25.9% | 74,077 | -31.6% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 108,321 | -6.6% | 0.00% | – |
| Q2 2022 | $3,000 | -85.0% | 115,985 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $20,000 | -71.0% | 115,985 | -2.0% | 0.00% | -80.0% |
| Q4 2021 | $69,000 | -18.8% | 118,333 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $85,000 | -30.9% | 118,333 | 0.0% | 0.01% | -37.5% |
| Q2 2021 | $123,000 | +13.9% | 118,333 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $108,000 | – | 118,333 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 66,666 | $675,993 | 0.02% |
| Arena Investors LP | 94,516 | $3,450 | 0.00% |
| Altium Capital Management LP | 133,333 | $4,820 | 0.00% |
| COWEN AND COMPANY, LLC | 202,371 | $8,196 | 0.00% |
| 683 Capital Management, LLC | 196,348 | $7,952 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Radcliffe Capital Management, L.P. | 33,333 | $1,205 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 22,697 | $1 | 0.00% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 66,665 | $2,200 | 0.00% |
| MORGAN STANLEY | 1,300 | $43 | 0.00% |